PolyVascular, a pioneering company focused on developing the world’s first polymeric, non-surgical pulmonary valve for pediatric patients, is excited to announce that Steven Girouard, PhD, an accomplished medical device executive and consultant, has joined its Board of Directors.

Steven brings a wealth of experience to PolyVascular, with a career spanning leadership roles at major medical device companies, including Johnson & Johnson and Guidant, as well as the Cleveland Clinic. He most recently served as President & CEO of Securus Medical, where he successfully guided the company through multiple rounds of financing, clinical trials, and FDA clearances before its acquisition by Boston Scientific. Steven has also held investment positions with Oakwood Medical Investors and Omega Funds, and currently serves on the boards of several other venture-backed startups. His background includes an impressive 50+ U.S. patents and a robust portfolio of peer-reviewed articles and book chapters.

“I am delighted to be part of the PolyVascular team and mission as we strive to bring the world’s first polymeric, non-surgical pulmonary valve and delivery system to the market for pediatric patients that so desperately deserve to be beneficiaries of medical device innovation and investment,” said Steven. “It’s a privilege to join a company that is dedicated to improving the lives of children with congenital heart defects.”

PolyVascular’s co-founder Dr. Henri Justino expressed the team’s enthusiasm for Girouard’s appointment: “We are thrilled to have Steven join our board. His extensive background in medical devices and his experience guiding companies from early stages to success will be invaluable as we advance toward clinical trials and market entry. His leadership and insight will help drive PolyVascular forward as we work to transform pediatric heart care.”

Steven holds a BS in Biomedical Engineering from Boston University and MS and PhD degrees in Biomedical Engineering from Case Western Reserve University.